Valuation Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 18/05/2026			5-day change	1st Jan Change
183,200.00 ^KRW	-2.97%		-4.23%	+1.22%

05-13	Celltrion USA, Inc. announced that it has received $516.1 million in funding from Celltrion, Inc.	CI
05-08	Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on April 22, 2026.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	27,592,583	23,000,359	27,970,378	40,365,453	39,602,284	38,396,964	-	-
Change	-	-16.64%	21.61%	44.32%	-1.89%	-3.04%	-	-
Enterprise Value (EV) ¹	27,117	23,236	29,280	41,531	42,173	40,363	39,459	38,696
Change	-	-14.31%	26.01%	41.84%	1.55%	-4.29%	-2.24%	-1.93%
P/E ratio	47.2x	41.6x	53.7x	91.7x	38.8x	29.3x	24.5x	21x
PBR	6.87x	5.34x	2.46x	2.2x	2.32x	2.18x	2.05x	1.88x
PEG	-	-9.54x	-20.3x	-2.1x	0x	0.9x	1.2x	1.3x
Capitalization / Revenue	14.6x	10.1x	12.9x	11.3x	9.51x	7.21x	6.27x	5.58x
EV / Revenue	14.3x	10.2x	13.5x	11.7x	10.1x	7.58x	6.45x	5.63x
EV / EBITDA	27.9x	26.6x	32.6x	45.6x	29x	19.5x	16.3x	13.9x
EV / EBIT	36x	35.9x	44.9x	84.4x	36.1x	23.4x	18.7x	15.7x
EV / FCF	46x	-211x	89.5x	54.2x	78.4x	38.8x	34.4x	26.1x
FCF Yield	2.17%	-0.47%	1.12%	1.85%	1.28%	2.58%	2.91%	3.83%
Dividend per Share ³	660.4	-	457.9	721.2	750	774.7	831.6	932.1
Rate of return	0.38%	-	0.25%	0.4%	0.41%	0.42%	0.45%	0.51%
EPS ³	3,691	3,530	3,437	1,966	4,660	6,247	7,490	8,733
Distribution rate	17.9%	-	13.3%	36.7%	16.1%	12.4%	11.1%	10.7%
Net sales ¹	1,891	2,284	2,176	3,557	4,162	5,327	6,121	6,878
EBITDA ¹	972.1	873.6	897.2	910.3	1,456	2,072	2,425	2,774
EBIT ¹	753.9	647.2	651.5	492	1,168	1,725	2,112	2,457
Net income ¹	575.1	533.2	535.6	422.7	1,030	1,403	1,679	1,942
Net Debt ¹	-475.5	235.5	1,310	1,165	2,571	1,966	1,062	299
Reference price ³	174,344.89	146,978.02	184,523.81	180,288.46	181,000.00	183,200.00	183,200.00	183,200.00
Nbr of stocks (in thousands)	158,264	156,488	151,581	223,894	218,797	209,590	-	-
Announcement Date	16/02/22	03/03/23	29/02/24	25/02/25	04/02/26	-	-	-

¹KRW in Million²KRW in Billions³KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CELLTRION, INC.	29.33x	7.58x	19.48x	0.42%	25.65B
LONZA GROUP AG	28.33x	5.04x	15.62x	1.16%	41.61B
BEONE MEDICINES AG	44.4x	4.44x	28.34x	-.--%	32.58B
REVOLUTION MEDICINES, INC.	-18.19x	275.29x	-16.37x	-.--%	30.69B
IQVIA HOLDINGS INC.	21.04x	2.47x	10.69x	-.--%	28.84B
IONIS PHARMACEUTICALS, INC.	-20.42x	13.21x	-20.47x	-.--%	11.98B
EUROFINS SCIENTIFIC SE	20.89x	1.85x	8.12x	1.28%	12.3B
MEDPACE HOLDINGS, INC.	24.69x	3.92x	17.83x	-.--%	12.01B
Average	16.26x	39.22x	7.90x	0.36%	24.46B
Weighted average by Cap.	19.09x	47.51x	9.95x	0.38%